Sonatherm® is a robotic laparoscopic probe used to deliver precise and focused ablative energy to soft tissue with a customizable zone of ablation.

Laparoscopic HIFU Surgical Ablation System

Care Capabilities

  • Short operating times
  • Quick patient recovery
  • Real-time imaging
  • Minimally invasive robotic ablation

Sonatherm Features

  • 4 MHz HIFU transducer
  • 35 mm focal length (30 mm ablation depth)
  • 6.5 MHz ultrasound imaging (biplanar) 
  • Compatible with 15 mm port
  • Conformal patient coupling
  • Single-use probe tip

Sonatherm ATechnology

Sonatherm® uses a robotic laparoscopic probe to deliver precise and focused ablative therapy to soft tissue with a customizable ablation zone. Sonatherm is powered by an exclusive focused ultrasound platform, known as Sonasource, which allows physicians to:

1. AIM

at specific tissue using integrated ultrasound imaging and sophisticated planning tools.



The Sonatherm® system uses high intensity focused ultrasound (HIFU) energy to ablate soft tissue within the body. HIFU waves are concentrated from the transducer (similar to a magnifying glass) into the ablation zone.

2. ABLATE

with pinpoint accuracy while sparing untargeted tissue.



During thermal ablation, the temperature rises rapidly causing complete cellular necrosis, destroying all targeted tissue. The ablation of soft tissue with the laparoscopic probe occurs from the ultrasound focal zone back to the surface of the targeted ablation area.

3. ANALYZE

procedure results using real-time ultrasound imaging.



The laparoscopic probe's robotic transducer is fully integrated with imaging and ablation crystals, combined within the same transducer.


Sonatherm® Disposables

Comprised of a sterile disposable probe tip and water path tubing. The disposable probe tip allows sterile patient contact necessary for acoustic coupling between the target tissue and energy source. The water path tubing connects the disposable probe tip directly to the Sonachill, which controls the temperature of the transducer by circulating sterile water.



Clinical Studies

Clinical studies for the continued evaluation of the safety and efficacy of the Sonatherm probe and device are currently in the planning stages. Updates and information will be posted shortly.



Regulatory Statement

Sonatherm® laparoscopic HIFU surgical ablation system has 510(K) clearance in the U.S., CE Marking and has obtained regulatory authorization in more than 30 countries outside the U.S. Sonatherm is indicated for the laparoscopic or intraoperative ablation of soft tissue from the ultrasound focal zone back to the surface of the targeted ablation area in General Surgery. Sonatherm is not to be used for non-invasive ablation, i.e. leaving intervening tissue spared, and it is not indicated for the ablation of Prostate tissue. Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.
 
 
 
 

Would you like more information about incorporating Sonatherm into your practice or hospital?

HIFU company

Contact

10130 Perimeter Pkwy, Suite 250
      Charlotte, NC 28216

(888) 874-4384

info@SonaCareMedical.com

Mon - Fri: 9:00 - 5:00

Latest News

23 May 2017

C-code goes into effect on July 1, 2017 affording greater opportunity to prostate patients in the United States Charlotte, NC, May 23, 2017 – SonaCare Medical, leading developer and manufacturer...

11 April 2017

Charlotte, NC (PR Newswire) April 11th, 2017 - SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the launch of an International Sonablate HIFU...